In a significant stride to fortify its COVID-19 response, Nepal has acquired over 377,000 Pfizer vaccine doses designated for booster inoculations. The Ministry of Health and Population orchestrated this initiative to cater to individuals with chronic conditions and those preparing for international travel.
Dr. Surendra Chaurasiya, Chief of the Supplies Management Section at the Department of Health Services, confirmed the arrival of these Pfizer shots, procured through COVAX, a pivotal arm of the Access to COVID-19 Tools.
This recent delivery supplements the earlier batch of 373,000 vaccine doses received on November 24 through COVAX. As part of COVAX’s commitment, Nepal is slated to receive a total of 750,000 booster shots to bolster its vaccination drive.
The spotlight now shifts to the efficient distribution of these vaccines, slated for dispatch to provincial health facilities. This strategic allocation aims to optimize accessibility and ensure that these critical booster doses reach those in need across the nation.
This move represents Nepal’s concerted effort to fortify its defense against the ongoing pandemic, catering to specific vulnerable groups and international travelers, reinforcing the country’s commitment to safeguarding public health on a global scale.
